/

Empresas

RI

No verificado

RION

Sobre qué escribimos

BiotecnologíaFarmacéuticaMedicina - VariosSaludSanidad

10 Comunicados de prensa

Ver todos los comunicados de prensa

11/11/2025

Veterinaria

Ciencia

Animales

Medicina - Varios

Sanidad

Biotecnología

Farmacéutica

Ir de compras

Salud

Mercado laboral

CORRECTING and REPLACING RION Launches RION Vet to Transform Animal Health with First-in-Class Biologic Therapeutic; Appoints Industry Leader Mark Herthel as CEO; Announces Series A Fulfillment

Fuente

Editor

1.00

0

11/11/2025

Mercado laboral

Veterinaria

Ciencia

Animales

Medicina - Varios

Sanidad

Biotecnología

Farmacéutica

Ir de compras

Salud

RION Launches Rion Vet to Transform Animal Health with First-in-Class Exosome Biologics; Appoints Industry Leader Mark Herthel as CEO; Announces Series A Fulfillment

Fuente

Editor

1.00

0

23/09/2025

Mercado laboral

Industria

Biotecnología

Farmacéutica

Sanidad

Salud

Ir de compras

RION Engages Lonza to Scale Manufacturing Exosome Based Therapeutics

Fuente

Editor

1.00

0

09/09/2025

Cosmética

Sanidad

Venta al público/Minorista

Tecnología

Farmacéutica

Ciencia

Oncología

VIH, SIDA y enfermedades autoinmunes

Ir de compras

Biología

Técnica

Medicina - Varios

Biotecnología

Salud

Mercado laboral

Industria

RION Launches INTENT Biologics to Develop Late-Stage Clinical Exosome-Based Therapies in Inflammation & Immunology; Appoints Biopharma Veteran Suneet Varma as CEO

Fuente

Editor

1.00

0

01/05/2025

Mercado laboral

Industria

Ciencia

Biotecnología

Farmacéutica

Sanidad

Salud

Medicina - Varios

RION names Biopharma Veteran Suneet Varma as Senior Advisor to Spearhead Expansion into Regenerative Therapeutics

Fuente

Editor

1.00

0

11/03/2025

Industria

Biotecnología

Salud

Sanidad

Farmacéutica

Ciencia

Material médico sanitario

Medicina - Varios

RION Announces First Patient Enrolled in Phase 1b Clinical Study Evaluating Purified Exosome Product™ (PEP™) for Knee Osteoarthritis

Fuente

Editor

1.00

0

13/01/2025

Análisis de Mercados

Ciencia

Biotecnología

Farmacéutica

Medicina - Varios

Salud

VIH, SIDA y enfermedades autoinmunes

RION Announces Final Patient Enrolled in the Phase 2 Clinical Study for Purified Exosome Product™ (PEP™) in Diabetic Foot Ulcers

Fuente

Editor

1.00

0

07/01/2025

Eventos

Ciencia

Biotecnología

Farmacéutica

Salud

Material médico sanitario

RION to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Fuente

Editor

1.00

0

25/09/2024

Mercado laboral

Biotecnología

Farmacéutica

Medicina - Varios

Sanidad

Salud

VIH, SIDA y enfermedades autoinmunes

RION Expands Leadership Team with the Appointment of Five Renowned Experts to Advisory Boards

Fuente

Editor

1.00

0

10/09/2024

Industria

Salud

Higiene alimentaria

Sanidad

Medicina - Varios

Ciencia

Farmacéutica

RION Announces Initiation of Phase 1b Clinical Study to Evaluate Purified Exosome Product™ (PEP™) for Knee Osteoarthritis

Fuente

Editor

1.00

0

Seguidores

0

Compatibilidad

0